[{"AccountsPayableCurrent_0_Q1_USD":215000000.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":1219900000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-12800000.0,"RepaymentsOfLongTermLinesOfCredit_1_Q1_USD":371400000.0,"OtherReceivablesNetCurrent_0_Q1_USD":66900000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":150300000.0,"PaymentsForSoftware_1_Q1_USD":31800000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":56200000.0,"DeferredFinanceCostsNet_0_Q1_USD":17900000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":400000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2455500000.0,"OtherLiabilitiesCurrent_0_Q1_USD":217600000.0,"EquityMethodInvestments_0_Q1_USD":20000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-29300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":1217100000.0,"RestrictedCashCurrent_0_Q1_USD":10700000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.12,"LongTermDebtCurrent_0_Q1_USD":26000000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":81500000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-25100000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-68900000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-118000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":403900000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":767500000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":3100000.0,"ProceedsFromIssuanceOfSeniorLongTermDebt_1_Q1_USD":79200000.0,"OtherAssetsNoncurrent_0_Q1_USD":217000000.0,"IncreaseDecreaseInOperatingCapital_1_Q1_USD":9800000.0,"BusinessCombinationIntegrationRelatedCosts_1_Q1_USD":76300000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":657700000.0,"RestructuringSettlementAndImpairmentProvisions_1_Q1_USD":74800000.0,"RestructuringReserveAccrualAdjustment1_1_Q1_USD":-600000.0,"RestructuringReserve_0_Q1_USD":11100000.0,"RestructuringCharges_1_Q1_USD":1600000.0,"ProceedsFromHedgeInvestingActivities_1_Q1_USD":25200000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0_Q1_USD":82100000.0,"PaymentsForRestructuring_1_Q1_USD":10800000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-500000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":400000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q1_USD":-11400000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":11100000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":-39200000.0,"NumberOfCountriesInWhichEntityOperates_0_Q1_country":90.0,"NoncurrentAssets_0_Q1_USD":1147400000.0,"LitigationReserve_0_Q1_USD":0.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q1_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-9300000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1_Q1_USD":1300000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":60500000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":192700000.0,"ContractWithCustomerLiability_0_Q1_USD":137600000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":872000000.0,"BusinessExitCosts1_1_Q1_USD":600000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"SeveranceCosts1_1_Q1_USD":400000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1100000.0,"LongTermDebt_0_Q1_USD":2061600000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":12600000.0,"NetIncomeLoss_1_Q1_USD":-49100000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":4300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-19600000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":896600000.0,"LiabilitiesCurrent_0_Q1_USD":707500000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":9727200000.0,"Liabilities_0_Q1_USD":3065700000.0,"InventoryNet_0_Q1_USD":1019000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-18700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-67800000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":132100000.0,"GainLossOnDispositionOfAssets_1_Q1_USD":3800000.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":8700000.0,"CostsAndExpenses_1_Q1_USD":725500000.0,"CommonStockValue_0_Q1_USD":0.0,"CommonStockSharesOutstanding_0_Q1_shares":398825969.0,"CommonStockSharesIssued_0_Q1_shares":398825969.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1206400000.0,"AssetsCurrent_0_Q1_USD":3120600000.0,"Assets_0_Q1_USD":9727200000.0,"AdditionalPaidInCapital_0_Q1_USD":6870300000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-242600000.0,"AccountsReceivableNetCurrent_0_Q1_USD":676800000.0,"DueToRelatedPartiesCurrent_0_Q1_USD":0.0,"LongTermDebtNoncurrent_0_Q1_USD":2035600000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":930100000.0,"StockholdersEquity_0_Q1_USD":6661500000.0,"InventoryRawMaterialsAndSupplies_0_Q1_USD":80700000.0,"InventoryLIFOReserve_0_Q1_USD":38000000.0,"Goodwill_0_Q1_USD":3004000000.0,"GainLossOnDispositionOfAssets1_1_Q1_USD":3800000.0,"EarningsPerShareBasic_1_Q1_USD":-0.12,"CostOfGoodsAndServicesSold_1_Q1_USD":332700000.0,"InventoryWorkInProcess_0_Q1_USD":592100000.0,"InventoryGross_0_Q1_USD":1057000000.0,"InventoryFinishedGoods_0_Q1_USD":384200000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.276,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":90200000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":33800000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":51600000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":919700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":403900000.0,"ShareBasedCompensation_1_Q1_USD":11100000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":182000000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":66800000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000000.0,"InterestExpense_1_Q1_USD":16500000.0,"CommonStockSharesAuthorized_0_Q1_shares":5000000000.0,"CommitmentsAndContingencies_0_Q1_USD":0.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":7400000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":-12800000.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200507"}]